0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Capitol Health Call | 
Rita Rubin, MA
JAMA. 2016;315(2):122. doi:10.1001/jama.2015.18246.

JAMA Clinical Challenge | 
Wenyu Huang, MD, PhD; Rukhsana G. Mirza, MD; Mark E. Molitch, MD
JAMA. 2015;314(23):2555-2556. doi:10.1001/jama.2015.9162.

From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2015;314(20):2184-2185. doi:10.1001/jama.2015.15427.

Viewpoint | 
Jonathan Silver, MD, MBA
JAMA. 2014;312(1):23-24. doi:10.1001/jama.2014.6672.

Viewpoint | 
Lee M. Jampol, MD; Neil M. Bressler, MD; Adam R. Glassman, MS
JAMA. 2014;311(22):2269-2270. doi:10.1001/jama.2014.2536.

Viewpoint | 
Rahul K. Nayak, BSE; Steven D. Pearson, MD, MSc; Franklin G. Miller, PhD
JAMA. 2014;311(15):1491-1492. doi:10.1001/jama.2014.1821.

Original Contribution |  FREE
The Age-Related Eye Disease Study 2 (AREDS2) Research Group*
JAMA. 2013;309(19):2005-2015. doi:10.1001/jama.2013.4997.
Includes: Supplemental Content

Original Contribution |  FREE
Barbara E. K. Klein, MD, MPH; Kerri P. Howard, MS; Ronald E. Gangnon, PhD; et al.
JAMA. 2012;308(23):2469-2478. doi:10.1001/jama.2012.65406.
Includes: Supplemental Content

Medical News & Perspectives | 
JAMA. 2002;288(4):440. doi:10.1001/jama.288.4.440-JMN0724-3-2.

Medical News & Perspectives | 
JAMA. 2000;283(22):2922. doi:10.1001/jama.283.22.2922-JMN0614-5-1.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Ophthalmology
Invited Commentary  | 
Physician-Industry Interactions and Anti–Vascular Endothelial Growth Factor Use Among US Ophthalmologists
Paul R. Lichter, MD
JAMA Ophthalmology
Original Investigation  | 
Physician-Industry Interactions and Anti–Vascular Endothelial Growth Factor Use Among US Ophthalmologists
Stanford C. Taylor, MD; Julia B. Huecker, MS; Mae O. Gordon, PhD; et al.
JAMA Ophthalmology
Ophthalmic Images  | 
Fernlike Maculopathy in a Patient With Central Retinal Vein Occlusion
Wai Kwan Lily Lai, MBBS, BSc; Mostafa A. Elgohary, MBChB, MSc, MD, FRCSEd, FRCSI, FRCOphth
JAMA Ophthalmology
Original Investigation  | 
Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment Analysis From the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial
Eric L. Ross, BA; David W. Hutton, PhD; Joshua D. Stein, MD, MS; et al.